Storia in 2 fonti

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Raccontata da

benzinga.com

morningstar.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo4 g fa

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

originale

benzinga.com6 g fa

Twist Bioscience Sees AI Drug Discovery Pipeline Expand - Twist Bioscience (NASDAQ:TWST)

Twist Bioscience beat Q3 ($118.4M, +23% YoY), forecasting triple-digit AI drug discovery growth for FY2027. Reaching EBITDA breakeven with >52% margins confirms pharma's strategic shift to AI-enabled discovery as core R&D infrastructure.

Leggi questa versione →

Timeline cronologica

lunedì 3 agosto 2026·benzinga.com
Twist Bioscience Sees AI Drug Discovery Pipeline Expand - Twist Bioscience (NASDAQ:TWST)
Twist Bioscience (NASDAQ: TWST) stock is up on strong Q3 results and raised guidance. AI drug discovery and NGS businesses show growth.
mercoledì 5 agosto 2026·morningstar.com
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock